Yuan Hong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yuan Hong has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
Xiaoming Guo
Department of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
10 shared publicationsYueli Zhu
Department of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
5 shared publicationsCaidi Ying
Ningbo Municipal Hospital of Traditional Chinese Medicine (TCM) Affiliated Hospital of Zhejiang Chinese Medical University Ningbo 315010 China
4 shared publicationsShiqi Gao
Department of Neurosurgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
4 shared publicationsXiaoyu Wang
Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
4 shared publications- Jianmin Zhang
Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
3 shared publications
Latest Publications
- Open Access
- 27 March 2026
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 481 (5) , 2035-2052
A novel cuproptosis-related prognostic gene signature is identified by machine learning and integrative analyses in gliomas
Recent studies have highlighted the impact of copper-induced cell death (cuproptosis) on cancer progression, prognosis, and treatment, but it remains unclear whether cuproptosis-related genes (CRGs) play any role in the glioma tumor microenvironment (TME). The CRGs expression patterns in TCGA glioma samples were evaluated based on genetic and transcriptional alterations identifying three different molecular groupings and showing that CRGs changes were linked to clinical characteristics, prognosis, and TME infiltration. Machine learning algorithms were then used to develop an overall survival score for cuproptosis-related prognostic genes (CRPGs), and its prognostic ability was validated for glioma patients. An elevated CRPGs score indicates a heightened mutation burden, increased glioma metabolism, compromised immunity, and strong correlation with both the cancer stem cells (CSC) index and medication sensitivity to chemotherapeutics. This extensive examination of CRGs in gliomas showed their possible significance in the tumor microenvironment as well as their prognostic value. This extremely precise CRPGs nomogram has furthered our understanding of cuproptosis in gliomas, which will allow new approaches to prognosis and immunotherapy development.
- 27 March 2026
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 481 (5) , 2035-2052
Open AccessA novel cuproptosis-related prognostic gene signature is identified by machine learning and integrative analyses in gliomas
Recent studies have highlighted the impact of copper-induced cell death (cuproptosis) on cancer progression, prognosis, and treatment, but it remains unclear whether cuproptosis-related genes (CRGs) play any role in the glioma tumor microenvironment (TME). The CRGs expression patterns in TCGA glioma samples were evaluated based on genetic and transcriptional alterations identifying three different molecular groupings and showing that CRGs changes were linked to clinical characteristics, prognosis, and TME infiltration. Machine learning algorithms were then used to develop an overall survival score for cuproptosis-related prognostic genes (CRPGs), and its prognostic ability was validated for glioma patients. An elevated CRPGs score indicates a heightened mutation burden, increased glioma metabolism, compromised immunity, and strong correlation with both the cancer stem cells (CSC) index and medication sensitivity to chemotherapeutics. This extensive examination of CRGs in gliomas showed their possible significance in the tumor microenvironment as well as their prognostic value. This extremely precise CRPGs nomogram has furthered our understanding of cuproptosis in gliomas, which will allow new approaches to prognosis and immunotherapy development.
- Open Access
- 4 March 2026
- Published by Ivyspring International Publisher in Theranostics
- Vol. 16 (10) , 5185-5203
Meningeal macrophages regulate fibroblasts to influence meningeal lymphatic function following traumatic brain injury
Background: The meningeal lymphatic system represents a critical pathway for cerebrospinal fluid exchange, waste clearance, and immune cell trafficking in the central nervous system. Although traumatic brain injury (TBI) induces marked alterations in meningeal immune cells, their role in regulating meningeal lymphatic function under physiological and pathological conditions remains unclear.
- 4 March 2026
- Published by Ivyspring International Publisher in Theranostics
- Vol. 16 (10) , 5185-5203
Open AccessMeningeal macrophages regulate fibroblasts to influence meningeal lymphatic function following traumatic brain injury
Background: The meningeal lymphatic system represents a critical pathway for cerebrospinal fluid exchange, waste clearance, and immune cell trafficking in the central nervous system. Although traumatic brain injury (TBI) induces marked alterations in meningeal immune cells, their role in regulating meningeal lymphatic function under physiological and pathological conditions remains unclear.
- Open Access
- 15 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-7
Risk factor and operation influence of intracranial hemorrhage following ventriculoperitoneal shunt
Intracranial hemorrhage is a rare but significant complication of ventriculoperitoneal (VP) shunt surgery. This study aimed to identify and assess the risk factors associated with intracranial hemorrhage in patients undergoing VP shunt surgery. This retrospective study included patients who underwent a VP shunt surgery between January 2021 and July 2023. The patients were stratified into two groups based on whether they had a history of prior neurosurgical procedures. Demographic and clinical variables were analyzed for their correlation with postoperative hemorrhage risk. Postoperative CT confirmed hemorrhage. Univariate and logistic regression analyses were performed. Among the 838 patients, 49 (5.85%) developed intracranial hemorrhage. In the overall cohort, preoperative (P = 0.037) and postoperative anticoagulant or antiplatelet use (P = 0.001), left-sided catheter placement (P = 0.026), and pericatheter edema (P = 0.052) were associated with hemorrhage. In patients without prior neurosurgery, independent predictors included pericatheter edema (P = 0.009), postoperative seizures (P < 0.001), shorter catheter depth (P = 0.022), and left-sided placement (P < 0.001). Postoperative anticoagulant use was significant in patients with prior neurosurgery (P = 0.004). Perioperative anticoagulant and antiplatelet use, left-sided catheter placement, and pericatheter edema are critical risk factors for intracranial hemorrhage after VP shunt surgery. Surgical planning should prioritize the vascular anatomy and minimize anticoagulant exposure.
- 15 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-7
Open AccessRisk factor and operation influence of intracranial hemorrhage following ventriculoperitoneal shunt
Intracranial hemorrhage is a rare but significant complication of ventriculoperitoneal (VP) shunt surgery. This study aimed to identify and assess the risk factors associated with intracranial hemorrhage in patients undergoing VP shunt surgery. This retrospective study included patients who underwent a VP shunt surgery between January 2021 and July 2023. The patients were stratified into two groups based on whether they had a history of prior neurosurgical procedures. Demographic and clinical variables were analyzed for their correlation with postoperative hemorrhage risk. Postoperative CT confirmed hemorrhage. Univariate and logistic regression analyses were performed. Among the 838 patients, 49 (5.85%) developed intracranial hemorrhage. In the overall cohort, preoperative (P = 0.037) and postoperative anticoagulant or antiplatelet use (P = 0.001), left-sided catheter placement (P = 0.026), and pericatheter edema (P = 0.052) were associated with hemorrhage. In patients without prior neurosurgery, independent predictors included pericatheter edema (P = 0.009), postoperative seizures (P < 0.001), shorter catheter depth (P = 0.022), and left-sided placement (P < 0.001). Postoperative anticoagulant use was significant in patients with prior neurosurgery (P = 0.004). Perioperative anticoagulant and antiplatelet use, left-sided catheter placement, and pericatheter edema are critical risk factors for intracranial hemorrhage after VP shunt surgery. Surgical planning should prioritize the vascular anatomy and minimize anticoagulant exposure.
- Open Access
- 3 July 2025
- Published by Wiley in Advanced Science
- Vol. 12 (35) , e15984
Choroid Plexus Fibroblast–ILC2 Niche Promotes Adult Hippocampal Neurogenesis after Traumatic Brain Injury
Mounting evidence has indicated that immune signals originating from the brain's border tissues will exert a profound influence on brain parenchyma neural cells. However, the structural component alterations and immune cell infiltration characteristics of choroid plexus (ChP) following traumatic brain injury (TBI) remain incompletely understood. Here, using single‐cell RNA sequencing and histological analysis, the accumulation of group 2 innate lymphoid cell (ILC2) in the ChP stroma post‐TBI is identified. Intracerebroventricular adoptive transfer of ILC2 is further indicated to exhibit a tendency to colonize the ChP and significantly alleviate pathogenic immune infiltration during the acute phase of TBI, as well as maintain hippocampal integrity during the chronic phase. Sensory‐motor function and memory impairments in TBI mice are also improved under ILC2 treatment. Mechanistically, ILC2 is induced by ChP fibroblasts derived IL33 and anchored to stroma fibroblasts via the VCAM‐1/Integrin α4β7 pathway. Furthermore, single‐nucleus RNA sequencing of the hippocampus reveals that ILC2‐derived AREG promotes the initiation of neurogenesis by interacting with EGFR on early‐stage neurogenic cells. Overall, these findings highlight that ChP‐resident ILC2, through optimizing the immune microenvironment and promoting neurogenesis after TBI, may represent a potential therapeutic strategy.
- 3 July 2025
- Published by Wiley in Advanced Science
- Vol. 12 (35) , e15984
Open AccessChoroid Plexus Fibroblast–ILC2 Niche Promotes Adult Hippocampal Neurogenesis after Traumatic Brain Injury
Mounting evidence has indicated that immune signals originating from the brain's border tissues will exert a profound influence on brain parenchyma neural cells. However, the structural component alterations and immune cell infiltration characteristics of choroid plexus (ChP) following traumatic brain injury (TBI) remain incompletely understood. Here, using single‐cell RNA sequencing and histological analysis, the accumulation of group 2 innate lymphoid cell (ILC2) in the ChP stroma post‐TBI is identified. Intracerebroventricular adoptive transfer of ILC2 is further indicated to exhibit a tendency to colonize the ChP and significantly alleviate pathogenic immune infiltration during the acute phase of TBI, as well as maintain hippocampal integrity during the chronic phase. Sensory‐motor function and memory impairments in TBI mice are also improved under ILC2 treatment. Mechanistically, ILC2 is induced by ChP fibroblasts derived IL33 and anchored to stroma fibroblasts via the VCAM‐1/Integrin α4β7 pathway. Furthermore, single‐nucleus RNA sequencing of the hippocampus reveals that ILC2‐derived AREG promotes the initiation of neurogenesis by interacting with EGFR on early‐stage neurogenic cells. Overall, these findings highlight that ChP‐resident ILC2, through optimizing the immune microenvironment and promoting neurogenesis after TBI, may represent a potential therapeutic strategy.
- Open Access
- 23 September 2023
- Published by Elsevier in Experimental Neurology
- Vol. 369, 114543
Stem cells in central nervous system diseases: Promising therapeutic strategies
- 23 September 2023
- Published by Elsevier in Experimental Neurology
- Vol. 369, 114543
Open AccessStem cells in central nervous system diseases: Promising therapeutic strategies
- Open Access
- 5 May 2023
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 29 (10) , 3062-3067
The impact of serum magnesium and calcium on the risk of epilepsy: A mendelian randomization study
Aims: To investigate the causal role of serum magnesium and calcium in epilepsy or any of its subtypes through Mendelian randomization (MR) approach.Methods: Single nucleotide polymorphisms (SNPs) associated with serum magnesium and calcium were used as the instrumental variables. MR analyses were performed using the summary‐level data for epilepsy extracted from International League Against Epilepsy Consortium (15,212 cases and 29,677 controls) to obtain the causal estimates. The analyses were replicated using FinnGen data (7224 epilepsy cases and 208,845 controls), and a meta‐analysis was then conducted.Results: The result of combined analyses showed that higher serum magnesium concentrations was associated with a reduced risk of overall epilepsy (odds ratios [OR] = 0.28, 95% confidence interval [CI], 0.12–0.62, p = 0.002). In ILAE, higher serum magnesium was suggestively associated with reduced risks of focal epilepsy (OR = 0.25, 95% CI 0.10–0.62, p = 0.003). However, the results cannot be repeated in sensitivity analyses. As for serum calcium, the results did not reach statistical significance with overall epilepsy (OR = 0.60, 95% CI, 0.31–1.17, p = 0.134). However, genetically predicted serum calcium concentrations showed an inverse association with risk of generalized epilepsy (OR = 0.35, 95% CI, 0.17–0.74, p = 0.006).Conclusion: The current MR analysis did not support a causal relationship between serum magnesium and epilepsy, but showed a causally negative association between genetically determined serum calcium and generalized epilepsy.
- 5 May 2023
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 29 (10) , 3062-3067
Open AccessThe impact of serum magnesium and calcium on the risk of epilepsy: A mendelian randomization study
Aims: To investigate the causal role of serum magnesium and calcium in epilepsy or any of its subtypes through Mendelian randomization (MR) approach.Methods: Single nucleotide polymorphisms (SNPs) associated with serum magnesium and calcium were used as the instrumental variables. MR analyses were performed using the summary‐level data for epilepsy extracted from International League Against Epilepsy Consortium (15,212 cases and 29,677 controls) to obtain the causal estimates. The analyses were replicated using FinnGen data (7224 epilepsy cases and 208,845 controls), and a meta‐analysis was then conducted.Results: The result of combined analyses showed that higher serum magnesium concentrations was associated with a reduced risk of overall epilepsy (odds ratios [OR] = 0.28, 95% confidence interval [CI], 0.12–0.62, p = 0.002). In ILAE, higher serum magnesium was suggestively associated with reduced risks of focal epilepsy (OR = 0.25, 95% CI 0.10–0.62, p = 0.003). However, the results cannot be repeated in sensitivity analyses. As for serum calcium, the results did not reach statistical significance with overall epilepsy (OR = 0.60, 95% CI, 0.31–1.17, p = 0.134). However, genetically predicted serum calcium concentrations showed an inverse association with risk of generalized epilepsy (OR = 0.35, 95% CI, 0.17–0.74, p = 0.006).Conclusion: The current MR analysis did not support a causal relationship between serum magnesium and epilepsy, but showed a causally negative association between genetically determined serum calcium and generalized epilepsy.
- Open Access
- 3 March 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1148458
Association between brain structures and migraine: A bidirectional Mendelian randomization study
Background: Accumulating evidence of clinical and neuroimaging studies indicated that migraine is related to brain structural alterations. However, it is still not clear whether the associations of brain structural alterations with migraine are likely to be causal, or could be explained by reverse causality confounding.Methods: We carried on a bidirectional Mendelian randomization analysis in order to identify the causal relationship between brain structures and migraine risk. Summary-level data and independent variants used as instruments came from large genome-wide association studies of total surface area and average thickness of cortex (33,992 participants), gray matter volume (8,428 participants), white matter hyperintensities (50,970 participants), hippocampal volume (33,536 participants), and migraine (102,084 cases and 771,257 controls).Results: We identified suggestive associations of the decreased surface area (OR = 0.85; 95% CI, 0.75–0.96; P = 0.007), and decreased hippocampal volume (OR = 0.74; 95% CI, 0.55–1.00; P = 0.047) with higher migraine risk. We did not find any significant association of gray matter volume, cortical thickness, or white matter hyperintensities with migraine. No evidence supporting the significant association was found in the reverse MR analysis.Conclusion: We provided suggestive evidence that surface area and hippocampal volume are causally associated with migraine risk.
- 3 March 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1148458
Open AccessAssociation between brain structures and migraine: A bidirectional Mendelian randomization study
Background: Accumulating evidence of clinical and neuroimaging studies indicated that migraine is related to brain structural alterations. However, it is still not clear whether the associations of brain structural alterations with migraine are likely to be causal, or could be explained by reverse causality confounding.Methods: We carried on a bidirectional Mendelian randomization analysis in order to identify the causal relationship between brain structures and migraine risk. Summary-level data and independent variants used as instruments came from large genome-wide association studies of total surface area and average thickness of cortex (33,992 participants), gray matter volume (8,428 participants), white matter hyperintensities (50,970 participants), hippocampal volume (33,536 participants), and migraine (102,084 cases and 771,257 controls).Results: We identified suggestive associations of the decreased surface area (OR = 0.85; 95% CI, 0.75–0.96; P = 0.007), and decreased hippocampal volume (OR = 0.74; 95% CI, 0.55–1.00; P = 0.047) with higher migraine risk. We did not find any significant association of gray matter volume, cortical thickness, or white matter hyperintensities with migraine. No evidence supporting the significant association was found in the reverse MR analysis.Conclusion: We provided suggestive evidence that surface area and hippocampal volume are causally associated with migraine risk.
- Open Access
- 12 May 2021
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 8
Endoscopic Endonasal Transclival Approach to Ventral Pontine Cavernous Malformation: Case Report
Ventral medial pontine cavernous malformations are challenging due to the location in eloquent tissue, surrounding critical anatomy, and potential symptomatic bleeding. Conventional approaches, such as anterolateral, lateral and dorsal approach, are associated with high risk of deleterious consequences due to excessive traction and damage to the surrounding tissues. The authors present an endoscopic endonasal approach for the resection of midline ventral pontine cavernous malformations, which follows principles of optimal access to brainstem cavernous malformations as the “two-point method.” No CSF leak or any other complications are obtained. The successful outcomes indicate that an individualized approach should be chosen before the surgery for brainstem cavernous malformations. With the advance of techniques, endoscopic endonasal approach could provide the most direct route to ventral pontine lesions with safety and efficiency.
- 12 May 2021
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 8
Open AccessEndoscopic Endonasal Transclival Approach to Ventral Pontine Cavernous Malformation: Case Report
Ventral medial pontine cavernous malformations are challenging due to the location in eloquent tissue, surrounding critical anatomy, and potential symptomatic bleeding. Conventional approaches, such as anterolateral, lateral and dorsal approach, are associated with high risk of deleterious consequences due to excessive traction and damage to the surrounding tissues. The authors present an endoscopic endonasal approach for the resection of midline ventral pontine cavernous malformations, which follows principles of optimal access to brainstem cavernous malformations as the “two-point method.” No CSF leak or any other complications are obtained. The successful outcomes indicate that an individualized approach should be chosen before the surgery for brainstem cavernous malformations. With the advance of techniques, endoscopic endonasal approach could provide the most direct route to ventral pontine lesions with safety and efficiency.
- Open Access
- 9 March 2021
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Peritumoral Edema Is Associated With Postoperative Hemorrhage and Reoperation Following Vestibular Schwannoma Surgery
Background: Postoperative hemorrhage (POH) is a severe complication following vestibular schwannoma surgery that may require surgical treatment. The purpose of our study is to identify risk factors associated with POH and reoperation following the resection of vestibular schwannoma.Methods: We retrospectively recruited 452 vestibular schwannoma patients treated with retrosigmoid approach. The primary outcome was POH, and the secondary outcome was reoperation for POH. Clinical and radiographic data were compared by performing univariate analysis and logistic regression analysis.Results: Among the 452 patients, 37 patients (8.2%) presented with POH and14 patients (3.1%) required reoperation within a 30-day hospitalization period. The univariate analysis showed that peritumoral edema, tumor diameter >30 mm, severe postoperative hypertension, and length of hospital stay were associated with POH and reoperation for POH. Logistic regression analysis showed that peritumoral edema [odds ratio (OR) 4.042, 95% confident interval (CI) 1.830–8.926, P = 0.001] and tumor diameter >30 mm (OR 3.192, 95% CI 1.421–7.168, P = 0.005) were independent predictive factors for POH. Peritumoral edema (OR 7.071, 95% CI 2.342–21.356, P = 0.001) was an independent predictive factor for reoperation by using logistic regression analysis. Further analysis revealed that larger tumor and incomplete tumor resection were both associated with a higher incidence of peritumoral edema.Conclusion: Peritumoral edema and tumor size are independent risk factors for POH following vestibular schwannoma surgery. And larger hematoma occurs more commonly in tumors with peritumoral edema which may require reoperation. Tumor size and extent of tumor resection are associated with peritumoral edema. Close attention should be paid to high-risk patients especially for those who presented with severe postoperative hypertension.
- 9 March 2021
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 11
Open AccessPeritumoral Edema Is Associated With Postoperative Hemorrhage and Reoperation Following Vestibular Schwannoma Surgery
Background: Postoperative hemorrhage (POH) is a severe complication following vestibular schwannoma surgery that may require surgical treatment. The purpose of our study is to identify risk factors associated with POH and reoperation following the resection of vestibular schwannoma.Methods: We retrospectively recruited 452 vestibular schwannoma patients treated with retrosigmoid approach. The primary outcome was POH, and the secondary outcome was reoperation for POH. Clinical and radiographic data were compared by performing univariate analysis and logistic regression analysis.Results: Among the 452 patients, 37 patients (8.2%) presented with POH and14 patients (3.1%) required reoperation within a 30-day hospitalization period. The univariate analysis showed that peritumoral edema, tumor diameter >30 mm, severe postoperative hypertension, and length of hospital stay were associated with POH and reoperation for POH. Logistic regression analysis showed that peritumoral edema [odds ratio (OR) 4.042, 95% confident interval (CI) 1.830–8.926, P = 0.001] and tumor diameter >30 mm (OR 3.192, 95% CI 1.421–7.168, P = 0.005) were independent predictive factors for POH. Peritumoral edema (OR 7.071, 95% CI 2.342–21.356, P = 0.001) was an independent predictive factor for reoperation by using logistic regression analysis. Further analysis revealed that larger tumor and incomplete tumor resection were both associated with a higher incidence of peritumoral edema.Conclusion: Peritumoral edema and tumor size are independent risk factors for POH following vestibular schwannoma surgery. And larger hematoma occurs more commonly in tumors with peritumoral edema which may require reoperation. Tumor size and extent of tumor resection are associated with peritumoral edema. Close attention should be paid to high-risk patients especially for those who presented with severe postoperative hypertension.
- Open Access
- 9 December 2020
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 11
SDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth via Targeting VEGFA
Background: Nonfunctioning pituitary neuroendocrine tumor (NF-PitNET) is difficult to resect. Except for surgery, there is no effective treatment for NF-PitNET. MicroRNA-134 (miR-134) has been reported to inhibit proliferation and invasion ability of tumor cells. Herein, the mechanism underlying the effect of miR-134 on alleviating NF-PitNET tumor cells growth is explored.Methods: Mouse pituitary αT3-1 cells were transfected with miR-134 mimics and inhibitor, followed by treatment with stromal cell-derived factor-1α (SDF-1α) in vitro. MiR-134 expression level: we used quantitative real-time PCR (qRT-PCR) to detect the expression of miR-134. Cell behavior level: cell viability and invasion ability were assessed using a cell counting kit-8 (CCK8) assay and Transwell invasion assay respectively. Cytomolecular level: tumor cell proliferation was evaluated by Ki-67 staining; propidium iodide (PI) staining analyzed the effect of miR-134 on cell cycle arrest; western blot analysis and immunofluorescence staining evaluated tumor migration and invasive ability. Additionally, we collected 27 NF-PitNET tumor specimens and related clinical data. The specimens were subjected to qRT-PCR to obtain the relative miR-134 expression level of each specimen; linear regression analysis was used to analyze the miR-134 expression level in tumor specimens and the age of the NF-PitNET population, gender, tumor invasion, prognosis, and other indicators.Results: In vitro experiment, miR-134 was observed to significantly inhibit αT3-1 cells proliferation characterized by inhibited cell viability and expressions of vascular endothelial growth factor A (VEGFA) and cell cycle transition from G1 to S phase (P < 0.01). VEGFA was verified as a target of miR-134. Additionally, miR-134-induced inhibition of αT3-1 cell proliferation and invasion was attenuated by SDF-1α and VEGFA overexpression (P < 0.01). In primary NF-PitNET tumor analysis, miR-134 expression level was negatively correlated with tumor invasion (P = 0.003).Conclusion: The regulation of the SDF-1α/miR-134/VEGFA axis represents a novel mechanism in the pathogenesis of NF-PitNETs and may serve as a potential therapeutic target for the treatment of NF-PitNETs.
- 9 December 2020
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 11
Open AccessSDF-1α/MicroRNA-134 Axis Regulates Nonfunctioning Pituitary Neuroendocrine Tumor Growth via Targeting VEGFA
Background: Nonfunctioning pituitary neuroendocrine tumor (NF-PitNET) is difficult to resect. Except for surgery, there is no effective treatment for NF-PitNET. MicroRNA-134 (miR-134) has been reported to inhibit proliferation and invasion ability of tumor cells. Herein, the mechanism underlying the effect of miR-134 on alleviating NF-PitNET tumor cells growth is explored.Methods: Mouse pituitary αT3-1 cells were transfected with miR-134 mimics and inhibitor, followed by treatment with stromal cell-derived factor-1α (SDF-1α) in vitro. MiR-134 expression level: we used quantitative real-time PCR (qRT-PCR) to detect the expression of miR-134. Cell behavior level: cell viability and invasion ability were assessed using a cell counting kit-8 (CCK8) assay and Transwell invasion assay respectively. Cytomolecular level: tumor cell proliferation was evaluated by Ki-67 staining; propidium iodide (PI) staining analyzed the effect of miR-134 on cell cycle arrest; western blot analysis and immunofluorescence staining evaluated tumor migration and invasive ability. Additionally, we collected 27 NF-PitNET tumor specimens and related clinical data. The specimens were subjected to qRT-PCR to obtain the relative miR-134 expression level of each specimen; linear regression analysis was used to analyze the miR-134 expression level in tumor specimens and the age of the NF-PitNET population, gender, tumor invasion, prognosis, and other indicators.Results: In vitro experiment, miR-134 was observed to significantly inhibit αT3-1 cells proliferation characterized by inhibited cell viability and expressions of vascular endothelial growth factor A (VEGFA) and cell cycle transition from G1 to S phase (P < 0.01). VEGFA was verified as a target of miR-134. Additionally, miR-134-induced inhibition of αT3-1 cell proliferation and invasion was attenuated by SDF-1α and VEGFA overexpression (P < 0.01). In primary NF-PitNET tumor analysis, miR-134 expression level was negatively correlated with tumor invasion (P = 0.003).Conclusion: The regulation of the SDF-1α/miR-134/VEGFA axis represents a novel mechanism in the pathogenesis of NF-PitNETs and may serve as a potential therapeutic target for the treatment of NF-PitNETs.